annual cash & cash equivalents:
$169.51M+$39.72M(+30.60%)Summary
- As of today (August 29, 2025), GPCR annual cash & cash equivalents is $169.51 million, with the most recent change of +$39.72 million (+30.60%) on December 31, 2024.
- During the last 3 years, GPCR annual cash & cash equivalents has risen by +$64.20 million (+60.97%).
- GPCR annual cash & cash equivalents is now at all-time high.
Performance
GPCR Cash and cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly cash & cash equivalents:
$786.51M-$50.38M(-6.02%)Summary
- As of today (August 29, 2025), GPCR quarterly cash & cash equivalents is $786.51 million, with the most recent change of -$50.38 million (-6.02%) on June 30, 2025.
- Over the past year, GPCR quarterly cash & cash equivalents has dropped by -$140.63 million (-15.17%).
- GPCR quarterly cash & cash equivalents is now -15.17% below its all-time high of $927.14 million, reached on June 30, 2024.
Performance
GPCR quarterly cash & cash equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and cash equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
GPCR Cash and cash equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +30.6% | -15.2% |
| 3 y3 years | +61.0% | - |
| 5 y5 years | +936.6% | +633.0% |
GPCR Cash and cash equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +549.7% | -15.2% | +765.8% |
| 5 y | 5-year | at high | +936.6% | -15.2% | +765.8% |
| alltime | all time | at high | +936.6% | -15.2% | +765.8% |
GPCR Cash and cash equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $786.51M(-6.0%) |
| Mar 2025 | - | $836.89M(-5.3%) |
| Dec 2024 | $169.51M(+30.6%) | $883.52M(-3.5%) |
| Sep 2024 | - | $915.29M(-1.3%) |
| Jun 2024 | - | $927.14M(+112.4%) |
| Mar 2024 | - | $436.44M(-6.6%) |
| Dec 2023 | $129.79M | $467.32M(+127.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $205.42M(-8.5%) |
| Jun 2023 | - | $224.58M(-6.8%) |
| Mar 2023 | - | $240.86M(+165.1%) |
| Dec 2022 | $26.09M(-75.2%) | $90.84M(-15.3%) |
| Dec 2021 | $105.31M(+544.0%) | - |
| Dec 2021 | - | $107.30M |
| Dec 2020 | $16.35M | - |
FAQ
- What is Structure Therapeutics Inc. annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. annual cash & cash equivalents year-on-year change?
- What is Structure Therapeutics Inc. quarterly cash & cash equivalents?
- What is the all time high quarterly cash & cash equivalents for Structure Therapeutics Inc.?
- What is Structure Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
What is Structure Therapeutics Inc. annual cash & cash equivalents?
The current annual cash & cash equivalents of GPCR is $169.51M
What is the all time high annual cash & cash equivalents for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high annual cash & cash equivalents is $169.51M
What is Structure Therapeutics Inc. annual cash & cash equivalents year-on-year change?
Over the past year, GPCR annual cash & cash equivalents has changed by +$39.72M (+30.60%)
What is Structure Therapeutics Inc. quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of GPCR is $786.51M
What is the all time high quarterly cash & cash equivalents for Structure Therapeutics Inc.?
Structure Therapeutics Inc. all-time high quarterly cash & cash equivalents is $927.14M
What is Structure Therapeutics Inc. quarterly cash & cash equivalents year-on-year change?
Over the past year, GPCR quarterly cash & cash equivalents has changed by -$140.63M (-15.17%)